Obama Care Covered California 2018 Premiums to Jum
Post# of 65629
Covered California announced this week that its 2018 rates [/url]will increase about eight times faster than the rate of inflation, as the Obamacare law and the state’s liberal legislature continue to destroy private insurance in California.
Despite the latest United States Department of Labor Consumer Price Index for the month of June estimating that inflation rose by only 1.6 percent over the last twelve months, Covered California, Obamacare for the state, just announced that the average health insurance premiums on the California insurance exchanges would rise by 12.5 percent, or about 7.81 times faster than the rate of inflation.
Covered California’s spiking prices are actually a relative bargain compared to the even worse Obamacare price increases insurers are about to extract across the rest of the nation. The Wall Street Journal recently reported that “big insurers in Idaho, West Virginia, South Carolina, Iowa, and Wyoming are seeking to raise premiums by 30 percent or more.”
The insurance industry lobbied the Democrat-controlled Congress in 2010 to design Obamacare to be more expensive than traditional private insurance by dramatically expanding services covered in the health benefit packages.
Section 1302 of the law granted also the Department of Health and Human Services the right to periodically revise an “essential health benefits package” of minimum health insurance coverage requirements. That allowed insurance companies to lobby federal bureaucrats to add more benefits and eliminate the standard lifetime caps on spending for wildly expensive treatments, such as inpatient drug rehabilitation.
Since the 2013-4 launch of Obamacare, premiums have risen by about 15 percent per year, despite inflation averaging only about 2 percent a year.
Not only were insurance companies making huge increases in revenue during the Obamacare years, their gross profit margins jumped from 22 percent, when Obamacare was passed in 2010, to 26 percent in the last quarter of 2016. Healthcare stocks have been the second-hottest sector in the seven-year bull market for stocks. Since Obamacare was passed on March 23, 2010, the healthcare stock index has risen by 248 percent.
The Trump presidential win appeared to represent an existential threat to the healthcare industry’s Obamacare bonanza. But with the Republican Senate failing to pass any type of Obamacare repeal, the healthcare stocks hit another all-time-high on July 31.
Many major healthcare companies that supported the expansion of Obamacare benefits and costs over the last seven years are now dropping out of the program as customers begin to take full advantage of the expanded and unlimited benefits.
United Healthcare, America’s largest healthcare insurer, announced in March 2016 that it was exiting all Obamacare exchanges after stating that Obamacare claims would reduce 2016 earnings by about $850 million. Still, four months later, United Healthcare recorded all-time-record quarterly revenues of $46.5 billion, a $10 billion increase over the prior year.
Covered California had been able to keep healthcare premium growth to around 10 percent per year because 11 healthcare insurers were participating. But Aetna dropped out at the end of 2016, and Anthem Blue Cross just announced they are dumping 153,000 customers and shutting down California operations in all regions except the rural north state, Central Valley, and Santa Clara County, according to the Orange County Register.
The 12.5 percent Covered California statewide increase is just an average. Abandoned United Healthcare subscribers can still buy coverage from Blue Shield, but their annual premium cost is expected to leap by 24 percent.
Covered California premium rates could jump statewide by another 16.6 percent if the Trump administration does not contest the May 12, 2016 ruling by U.S. District Judge Rosemary M. Collyer in United States House of Representatives v. Price that the Obama administration improperly amended Obamacare in January 2014 to pay billions in cost-sharing subsidies to insurers without congressional approval.